Silke Holtkamp

700 total citations
8 papers, 496 citations indexed

About

Silke Holtkamp is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Silke Holtkamp has authored 8 papers receiving a total of 496 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 3 papers in Molecular Biology and 3 papers in Immunology. Recurrent topics in Silke Holtkamp's work include CAR-T cell therapy research (7 papers), Acute Lymphoblastic Leukemia research (2 papers) and Biosimilars and Bioanalytical Methods (2 papers). Silke Holtkamp is often cited by papers focused on CAR-T cell therapy research (7 papers), Acute Lymphoblastic Leukemia research (2 papers) and Biosimilars and Bioanalytical Methods (2 papers). Silke Holtkamp collaborates with scholars based in Germany, Austria and Spain. Silke Holtkamp's co-authors include Abderraouf Selmi, Özlem Türeci, Petra Simon, Michael Koslowski, Christoph Huber, Sebastian Kreiter, Uğur Şahin, Péter Reményi, Peter Borchmann and Francis Ayuk and has published in prestigious journals such as Blood, RMD Open and Hematological Oncology.

In The Last Decade

Silke Holtkamp

8 papers receiving 478 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Silke Holtkamp Germany 4 363 200 130 115 91 8 496
Abderaouf Selmi Germany 6 374 1.0× 275 1.4× 109 0.8× 117 1.0× 58 0.6× 7 508
Joshua Glover United States 6 284 0.8× 163 0.8× 126 1.0× 153 1.3× 85 0.9× 7 473
Justin S. Antony Germany 15 438 1.2× 156 0.8× 181 1.4× 109 0.9× 75 0.8× 33 669
M. Wright United States 7 362 1.0× 154 0.8× 169 1.3× 110 1.0× 84 0.9× 9 484
Derek T. Cummings Canada 10 226 0.6× 209 1.0× 216 1.7× 146 1.3× 74 0.8× 16 502
Aurélie Bouteau United States 7 311 0.9× 228 1.1× 58 0.4× 39 0.3× 173 1.9× 10 520
Céline Robert-Tissot United States 10 188 0.5× 255 1.3× 60 0.5× 191 1.7× 39 0.4× 15 430
Samir Andrade Mendonça Brazil 7 134 0.4× 136 0.7× 100 0.8× 90 0.8× 140 1.5× 13 393
Kristen Hopson United States 7 378 1.0× 387 1.9× 60 0.5× 235 2.0× 74 0.8× 8 563
Evelien Naessens Belgium 13 213 0.6× 294 1.5× 93 0.7× 60 0.5× 118 1.3× 26 620

Countries citing papers authored by Silke Holtkamp

Since Specialization
Citations

This map shows the geographic impact of Silke Holtkamp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Silke Holtkamp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Silke Holtkamp more than expected).

Fields of papers citing papers by Silke Holtkamp

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Silke Holtkamp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Silke Holtkamp. The network helps show where Silke Holtkamp may publish in the future.

Co-authorship network of co-authors of Silke Holtkamp

This figure shows the co-authorship network connecting the top 25 collaborators of Silke Holtkamp. A scholar is included among the top collaborators of Silke Holtkamp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Silke Holtkamp. Silke Holtkamp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
2.
Borchmann, Peter, Álvaro Urbano-Ispizúa, François Lemonnier, et al.. (2023). A RANDOMIZED PHASE II STUDY OF MB‐CART2019.1 COMPARED TO STANDARD OF CARE IN PATIENTS WITH RELAPSED/REFRACTORY DLBCL INELIGIBLE FOR ASCT – DALY 2‐EU TRIAL. Hematological Oncology. 41(S2). 840–841. 3 indexed citations
3.
Gödel, Philipp, Hyatt Balke‐Want, Francis Ayuk, et al.. (2022). P1184: PHASE I TRIAL OF MB-CART2019.1 IN PATIENTES WITH RELAPSED OR REFRATORY B-CELL NON-HODGKIN LYMPHOMA: 2 YEAR FOLLOW-UP REPORT. HemaSphere. 6. 1070–1071. 2 indexed citations
4.
5.
Mackensen, Andréas, Linda Hanssens, Matthias Stelljes, et al.. (2021). A Phase I Open Label Dose Escalation Study of MB-CART19.1 in Relapsed and Refractory CD19+ B Cell Malignancies, Interim Preliminary Results in Pediatric ALL, Adult ALL Including CLL Cohorts. Blood. 138(Supplement 1). 3836–3836. 2 indexed citations
6.
Borchmann, Peter, Philipp Gödel, Hyatt Balke‐Want, et al.. (2020). Phase I Trial of MB-CART2019.1, a Novel CD20 and CD19 Targeting Tandem Chimeric Antigen Receptor, in Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma. Blood. 136(Supplement 1). 48–48. 10 indexed citations
7.
8.
Holtkamp, Silke, Sebastian Kreiter, Abderraouf Selmi, et al.. (2006). Modification of antigen-encoding RNA increases stability, translational efficacy, and T-cell stimulatory capacity of dendritic cells. Blood. 108(13). 4009–4017. 465 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Abderaouf Selmi Breakdown of academic impact, for papers by Joshua Glover Breakdown of academic impact, for papers by Justin S. Antony Breakdown of academic impact, for papers by M. Wright Breakdown of academic impact, for papers by Derek T. Cummings Breakdown of academic impact, for papers by Aurélie Bouteau Breakdown of academic impact, for papers by Céline Robert-Tissot Breakdown of academic impact, for papers by Samir Andrade Mendonça Breakdown of academic impact, for papers by Kristen Hopson Breakdown of academic impact, for papers by Evelien Naessens
Rankless by CCL
2026